Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06155396 |
| Consolidated Lead Sponsor | RemeGen Co |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 116 participants (ESTIMATED) |
| Registered Start Date | 2024-01-11 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| The First Affiliated Hospital of Bengbu Medical College | Bengbu, China | Open Hospital Dossier -> |
| Chongqing University Cancer Hospital | Chongqing, China | Open Hospital Dossier -> |
| Hunan Cancer Hospital | Changsha, China | Open Hospital Dossier -> |
| Liaoning Cancer Hospital & Institute | Shenyang, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.